Autism Spectrum Disorder Risk in Relation to Maternal Mid-Pregnancy Serum Hormone and Protein Markers from Prenatal Screening in California.
Second-trimester hormone markers give a small but real hint about later autism risk.
01Research in Context
What this study did
Doctors tested leftover blood from routine prenatal screens. They looked at three hormone levels taken around week 17 of pregnancy.
They matched these lab values to later autism diagnoses in California kids. The sample was large and came from state birth records.
What they found
Low estriol, high alpha-fetoprotein, and very high or very low hCG each nudged autism odds up a little.
The shifts were small, but they showed up across thousands of pregnancies.
How this fits with other research
Deserno et al. (2017) and Aller et al. (2023) tell a similar story. They used mom’s body hair or testosterone levels as stand-ins for hormones and also saw a slight rise in autism odds.
Granillo et al. (2022) looks like a clash at first. They found no link between mom’s androgens and autism in high-risk baby brothers and sisters. The key difference is the group they studied. Lauren’s team only looked at siblings who already had a higher chance of autism. In that already-loaded deck, hormone levels did not add new information.
Zhu et al. (2020) widen the lens. Their meta-analysis shows moms with autoimmune diseases like lupus also have slightly more kids with autism. Hormones and immune problems may both sit on the same early-pregnancy pathway.
Why it matters
You cannot change prenatal hormones, but you can use the clue. When a chart shows odd second-trimester lab values, flag it for closer developmental watch. Pair this with questions about autoimmune history. The signal is weak, so it will not change diagnosis, but it can speed referral if delays show up later.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add one question about unusual prenatal lab results to your caregiver intake form.
02At a glance
03Original abstract
We examined prenatal screening markers and offspring autism spectrum disorder (ASD) using California statewide data on singleton births in 1996 and 2002. Second trimester levels of unconjugated estriol (uE3), human chorionic gonadotropin (hCG), and maternal serum alpha-fetoprotein (MSAFP) were compared between mothers of children with ASD (n = 2586) and of non-cases (n = 600,103). Adjusted odds ratios (AOR) were calculated by logistic regression. Lower uE3 (AOR for < 10th percentile vs. 25th-74th percentiles = 1.21, 95 % CI 1.06-1.37), and higher MSAFP (AOR = 1.21, 95 % CI 1.07-1.37 for > 90th percentile) were significantly associated with ASD. A U-shaped relationship was seen for hCG (AOR = 1.16, 95 % CI 1.02-1.32 for < 10th percentile; AOR = 1.19, 95 % CI 1.05-1.36 for > 90th percentile). Our results further support prenatal hormone involvement in ASD risk.
Journal of autism and developmental disorders, 2016 · doi:10.1007/s10803-015-2587-2